Tivorsan Pharmaceuticals

Tivorsan develops protein therapeutics for the treatment of neuromuscular disorders that includes duchenne and becker muscular dystrophy.

Business Model:

Revenue: $0

Employees: 1-10

Rankings

Detailed Tivorsan Pharmaceuticals Information

Geographic Data

Tivorsan Pharmaceuticals headquarters map

Address: 3 Davol Sq

City: Providence

State: RI

Zip: 02903

Country: US

Financial Info

Stage:

series unknown

Raised Last:

$4M

Raised Total:

$2M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Tivorsan develops protein therapeutics for the treatment of neuromuscular disorders that includes duchenne and becker muscular dystrophy.

Contact Phone:
+14104192171

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
11/2014 Venture Round $1.6M
2/2016 Venture Round $1.8M
1/2012 Venture Round 1 $1M MDA
MDA
2/2013 Venture Round $2.8M
2/2011 Venture Round $1.1M
3/2017 Venture Round $4.5M
2/2012 Grant $0 Parent Project Muscular Dystrophy
Parent Project Muscular Dystrophy
2/2012 Grant 1 $500k Parent Project Muscular Dystrophy
Parent Project Muscular Dystrophy
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research